Creating new topical treatments for psoriasis
Development of Novel Topical Therapeutics for Psoriasis
This study is working on new skin treatments for psoriasis that aim to be safer and more effective, helping people with this condition feel better by improving how skin and immune cells interact.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biotherapeutics, INC. NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-10698601 on NIH RePORTER |
What this research studies
This research focuses on developing innovative topical therapies specifically for psoriasis, a chronic autoimmune condition affecting millions. The approach combines advanced computational modeling with experimental methods to create safer and more effective treatment options. Current treatments often have limited efficacy and significant side effects, leading to a need for new solutions. The goal is to create a first-in-class therapeutic that targets the interaction between skin cells and immune cells to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from psoriasis who are seeking more effective treatment options.
Not a fit: Patients with psoriasis who are currently satisfied with their existing treatments may not find additional benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with safer and more effective topical treatments for psoriasis, reducing side effects and improving quality of life.
How similar studies have performed: Other research has shown promise in developing novel therapies for psoriasis, but this specific approach is innovative and aims to address unmet clinical needs.
Where this research is happening
Blacksburg, United States
- Biotherapeutics, INC. — Blacksburg, United States (Active)
Researchers
- Principal investigator: Tubau Juni, Nuria — Biotherapeutics, INC.
- Study coordinator: Tubau Juni, Nuria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.